BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Aizawa Y, Seki N, Nagano T, Abe H. Chronic hepatitis C virus infection and lipoprotein metabolism. World J Gastroenterol 2015; 21(36): 10299-10313 [PMID: 26420957 DOI: 10.3748/wjg.v21.i36.10299]
URL: https://www.wjgnet.com/1007-9327/full/v21/i36/10299.htm
Number Citing Articles
1
Emilie Crouchet, Thomas F. Baumert, Catherine Schuster. Hepatitis C virus–apolipoprotein interactions: molecular mechanisms and clinical impactExpert Review of Proteomics 2017; 14(7): 593 doi: 10.1080/14789450.2017.1344102
2
Joana Rita Carvalho, José Velosa, Fátima Serejo. Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication – comparison of the new direct-acting antiviral agents with the old regimensScandinavian Journal of Gastroenterology 2018; 53(7): 857 doi: 10.1080/00365521.2018.1473486
3
Takeshi Chida, Kazuhito Kawata, Kazuyoshi Ohta, Erika Matsunaga, Jun Ito, Shin Shimoyama, Satoru Yamazaki, Hidenao Noritake, Tetsuro Suzuki, Takafumi Suda, Yoshimasa Kobayashi. Rapid Changes in Serum Lipid Profiles during Combination Therapy with Daclatasvir and Asunaprevir in Patients Infected with Hepatitis C Virus Genotype 1bGut and Liver 2018; 12(2): 201 doi: 10.5009/gnl17179
4
Laura Pellegrini, Anna Albecka, Donna L. Mallery, Max J. Kellner, David Paul, Andrew P. Carter, Leo C. James, Madeline A. Lancaster. SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain OrganoidsCell Stem Cell 2020; 27(6): 951 doi: 10.1016/j.stem.2020.10.001
5
Mohamed Shengir, Mohamed Elgara, Giada Sebastiani. Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyondWorld Journal of Gastroenterology 2021; 27(17): 1959-1972 doi: 10.3748/wjg.v27.i17.1959
6
Takako Inoue, Takaaki Goto, Etsuko Iio, Kayoko Matsunami, Kei Fujiwara, Noboru Shinkai, Kentaro Matsuura, Takeshi Matsui, Shunsuke Nojiri, Yasuhito Tanaka. Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virusHepatology Research 2018; 48(3): E203 doi: 10.1111/hepr.12970
7
ARZU ALTUNÇEKİÇ YILDIRIM, Selma Cırrık, Yeliz Çetinkol, Mustafa Kerem Çalgın, Tevfik Noyan. Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control studyJournal of Surgery and Medicine 2019;  doi: 10.28982/josam.595537
8
Srikanta Dash, Srinivas Chava, Yucel Aydin, Partha Chandra, Pauline Ferraris, Weina Chen, Luis Balart, Tong Wu, Robert Garry. Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress ResponseViruses 2016; 8(5): 150 doi: 10.3390/v8050150
9
Gilmar de Souza Lacerda, Thalia Medeiros, Natalia Fonseca do Rosário, Regina Helena Saramago Peralta, Mauro Jorge Cabral-Castro, Eliane Bordalo Cathalá Esberard, Thaís Guaraná de Andrade, Analúcia Rampazzo Xavier, Andrea Alice Silva. Exploring lipid and apolipoprotein levels in chronic hepatitis C patients according to their response to antiviral treatmentClinical Biochemistry 2018; 60: 17 doi: 10.1016/j.clinbiochem.2018.07.007
10
Alaa Badawi, Giancarlo Di Giuseppe, Paul Arora, Hans Tillmann. Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017)PLOS ONE 2018; 13(12): e0208839 doi: 10.1371/journal.pone.0208839
11
Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska. Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA TherapyCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6150861
12
Daisuke Morihara, Yi‐Ling Ko, Kumiko Shibata, Ryo Yamauchi, Hiromi Fukuda, Naoaki Tsuchiya, Atsushi Fukunaga, Hideo Kunimoto, Hideyuki Iwashita, Kazuhide Takata, Takashi Tanaka, Kunitoshi Sakurai, Shinjiro Inomata, Keiji Yokoyama, Shinya Nishizawa, Yasuaki Takeyama, Makoto Irie, Satoshi Shakado, Tetsuro Sohda, Shotaro Sakisaka. IL28B gene polymorphism is correlated with changes in low‐density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct‐acting antiviral treatment Journal of Gastroenterology and Hepatology 2019; 34(11): 2019 doi: 10.1111/jgh.14741
13
Chengliang Zhu, Guosheng Gao, Hui Song, Fengxia Xu, Kailang Wu, Xinghui Liu. Hepatitis B virus inhibits apolipoprotein A5 expression through its core geneLipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0340-2
14
Florian Wrensch, Emilie Crouchet, Gaetan Ligat, Mirjam B. Zeisel, Zhen-Yong Keck, Steven K. H. Foung, Catherine Schuster, Thomas F. Baumert. Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine DesignFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01436
15
Jihong Lian, Randal Nelson, Richard Lehner. Carboxylesterases in lipid metabolism: from mouse to humanProtein & Cell 2018; 9(2): 178 doi: 10.1007/s13238-017-0437-z
16
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ferdinando C Sasso, Pia C Pafundi, Barbara Guerrera, Aldo Marrone, Mauro Giordano, Luigi E Adinolfi. Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antiviralsJGH Open 2020; 4(4): 713 doi: 10.1002/jgh3.12324
17
Rie Harada, Masako Kimura, Yasushi Sato, Tatsuya Taniguchi, Tetsu Tomonari, Takahiro Tanaka, Hironori Tanaka, Naoki Muguruma, Hirohiko Shinomiya, Hirohito Honda, Issei Imoto, Masahiro Sogabe, Toshiya Okahisa, Tetsuji Takayama. APOB codon 4311 polymorphism is associated with hepatitis C virus infection through altered lipid metabolismBMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0747-5
18
Ruirui Feng, Xiaozhong Guo, Yun Kou, Xiangbo Xu, Cen Hong, Wenwen Zhang, Yang An, Cyriac Abby Philips, Andrea Mancuso, Xingshun Qi. Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosisPostgraduate Medicine 2021; : 1 doi: 10.1080/00325481.2021.1930560
19
M. Sidorkiewicz, M. Grek, B. Jozwiak, A. Krol, A. Piekarska. The impact of chronic hepatitis C infection on cholesterol metabolism in PBMCs is associated with microRNA-146a expressionEuropean Journal of Clinical Microbiology & Infectious Diseases 2017; 36(4): 697 doi: 10.1007/s10096-016-2851-1
20
Kunitada Shimotohno. HCV Assembly and Egress via Modifications in Host Lipid Metabolic SystemsCold Spring Harbor Perspectives in Medicine 2021; 11(1): a036814 doi: 10.1101/cshperspect.a036814
21
Daisuke Endo, Kenichi Satoh, Noritomo Shimada, Atsushi Hokari, Yoshio Aizawa. Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1bWorld Journal of Gastroenterology 2017; 23(13): 2355-2364 doi: 10.3748/wjg.v23.i13.2355
22
Ashraf O. Abdelaziz, Hend I. Shousha, Ebada M. Said, Zeinab A. Soliman, Ahmed A. Shehata, Mohamed M. Nabil, Ahmed H. Abdelmaksoud, Tamer M. Elbaz, Fatma M. Abdelsalam. Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinomaEuropean Journal of Gastroenterology & Hepatology 2018; 30(11): 1384 doi: 10.1097/MEG.0000000000001196
23
Mohammed A. Sarhan, Mohamed S. Abdel-Hakeem, Andrew L. Mason, D. Lorne Tyrrell, Michael Houghton. Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolismScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-02648-6
24
Leonor Jacobo-Albavera, Mayra Domínguez-Pérez, Diana Jhoseline Medina-Leyte, Antonia González-Garrido, Teresa Villarreal-Molina. The Role of the ATP-Binding Cassette A1 (ABCA1) in Human DiseaseInternational Journal of Molecular Sciences 2021; 22(4): 1593 doi: 10.3390/ijms22041593
25
Eric Piver, Audrey Boyer, Julien Gaillard, Anne Bull, Elodie Beaumont, Philippe Roingeard, Jean-Christophe Meunier. Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocaptureGut 2017; 66(8): 1487 doi: 10.1136/gutjnl-2016-311726
26
Srikanta Dash, Yucel Aydin, Christopher M. Stephens. Viral Polymerases2019; : 211 doi: 10.1016/B978-0-12-815422-9.00008-5
27
Yuyan Gui, Nan Chu, Xuemin Qiu, Wei Tang, Hans-Jürgen Gober, Dajin Li, Ling Wang. 17-β-estradiol up-regulates apolipoprotein genes expression during osteoblast differentiation <i>in vitro </i>BioScience Trends 2016; 10(2): 140 doi: 10.5582/bst.2016.01007
28
Kylie Su Mei Yong, Zhisheng Her, Qingfeng Chen. Humanized Mouse Models for the Study of Hepatitis C and Host InteractionsCells 2019; 8(6): 604 doi: 10.3390/cells8060604
29
Amr Ali Hemeda, Amal Ahmad Mohamed, Ramy Karam Aziz, Mohamed S. Abdel-Hakeem, Marwa Ali-Tammam. Impact of IL10, MTP, SOD2, and APOE Gene Polymorphisms on the Severity of Liver Fibrosis Induced by HCV Genotype 4Viruses 2021; 13(4): 714 doi: 10.3390/v13040714